XML 46 R9.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Additional paid-in capital
Treasury shares
Company shares held by ESOP
Retained earnings
Accumulated other comprehensive loss
Ordinary shares
Ordinary shares
Common stock
Deferred shares
Deferred shares
Common stock
Beginning balance at Dec. 31, 2019 $ 174.4 $ 68.4 $ (4.0) $ (1.7) $ 84.8 $ (149.6)   $ 26.6   $ 149.9
Beginning balance (in shares) at Dec. 31, 2019     (400,000) (1,200,000)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 20.0       20.0          
Shares sold from ESOP 1.1 0.8   $ 0.3            
Shares sold from ESOP (in shares)       100,000            
Other comprehensive (loss) income, net of tax (16.2)         (16.2)        
Dividends declared and paid (13.6)       (13.6)          
Share based compensation 2.8 2.8                
Utilization of treasury shares to satisfy share based compensation (0.1) (0.1)                
Utilization of shares from ESOP to satisfy share-based compensation (1.3) (1.3)                
Utilization of shares from ESOP to satisfy share based compensation (in shares)       100,000            
Ending balance at Dec. 31, 2020 167.1 70.6 $ (4.0) $ (1.4) 91.2 (165.8)   26.6   149.9
Ending balance (in shares) at Dec. 31, 2020     (400,000) (1,000,000.0)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 29.9       29.9          
Other comprehensive (loss) income, net of tax 30.8         30.8        
Dividends declared and paid (13.6)       (13.6)          
Share based compensation 2.8 2.8                
Utilization of treasury shares to satisfy share based compensation 0.0 (0.1) $ 0.1              
Utilization of shares from ESOP to satisfy share-based compensation (1.5) (1.8)   $ 0.3            
Utilization of shares from ESOP to satisfy share based compensation (in shares)       200,000            
Repurchase of ordinary shares (in shares)     (300,000)              
Repurchase of ordinary shares (6.4)   $ (6.4)              
Cancellation of ordinary shares 0.0 (0.6) $ 0.7         (0.1)    
Cancellation of ordinary shares (in shares)     100,000              
Ending balance at Dec. 31, 2021 209.1 70.9 $ (9.6) $ (1.1) 107.5 (135.0)   26.5   149.9
Ending balance (in shares) at Dec. 31, 2021     (600,000) (800,000)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 26.9       26.9          
Shares sold from ESOP (in shares)             0   15,977,968,688  
Other comprehensive (loss) income, net of tax (4.4)         (4.4)        
Dividends declared and paid (14.2)       (14.2)          
Share based compensation 2.5 2.5                
Utilization of treasury shares to satisfy share based compensation (0.4) (0.7) $ 0.3              
Utilization of shares from ESOP to satisfy share-based compensation (1.0) (1.1)   $ 0.1            
Utilization of shares from ESOP to satisfy share based compensation (in shares)       100,000            
Repurchase of ordinary shares (in shares)     (700,000)              
Repurchase of ordinary shares (11.1)   $ (11.1)              
Cancellation of deferred shares (0.1) 149.8               (149.9)
Ending balance at Dec. 31, 2022 $ 207.3 $ 221.4 $ (20.4) $ (1.0) $ 120.2 $ (139.4)   $ 26.5   $ 0.0
Ending balance (in shares) at Dec. 31, 2022     (1,300,000) (700,000)